ClinicalTrials.gov
public full text
Public Domain
Accelerated cTBS on Metabolic Dysfunction in People With Schizophrenia
cTBS is a promising novel intervention, which has strong potential on moderating disease syndrome. However, the most effective pattern of the cTBS is still under debate. Therefore, the investigators designed this randomized controlled clinical trial to evaluate the efficacy and safety of accelerated cTBS, with 1800 stimulation per session, on intervention to metabolic side effects in individuals with schizophrenia.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)#148728
- Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability#394742
- Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics#314308
- Early Nutritional Intervention in Patients With Autism Spectrum Disorders#811860
- Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic Syndrome#474898
Record · ID 831000
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive